Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by XPENG INC.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
F-6EF | Document | Auto effective registration statement for American Depositary Receipts representing securities of certain foreign private issuers Acc-no: 0001193805-24-001115 (33 Act) Size: KB |
Sep-13-2024 | 241296595 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-24-218494 (33 Act) Size: KB |
Sep-13-2024 | 241296555 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-006804 (33 Act) Size: 0 KB |
Sep-04-2024 | 241278030 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-211475 (34 Act) Size: KB |
Sep-03-2024 | 241271796 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-206648 (34 Act) Size: KB |
Aug-26-2024 | 241237707 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-006433 (33 Act) Size: 0 KB |
Aug-23-2024 | 241236576 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-006417 (33 Act) Size: 0 KB |
Aug-22-2024 | 241233112 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-203410 (34 Act) Size: KB |
Aug-20-2024 | 241223445 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-199438 (34 Act) Size: KB |
Aug-13-2024 | 241198898 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-191479 (34 Act) Size: KB |
Aug-01-2024 | 241166442 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-181903 (34 Act) Size: KB |
Jul-22-2024 | 241129173 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-178561 (34 Act) Size: KB |
Jul-12-2024 | 241114464 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-175596 (34 Act) Size: KB |
Jul-05-2024 | 241102632 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-174049 (34 Act) Size: KB |
Jul-02-2024 | 241093465 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-172228 (34 Act) Size: KB |
Jun-28-2024 | 241085531 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-004902 (33 Act) Size: 0 KB |
Jun-18-2024 | 241052773 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-004852 (33 Act) Size: 0 KB |
Jun-17-2024 | 241049280 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-004552 (33 Act) Size: 0 KB |
Jun-10-2024 | 241033457 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-153008 (34 Act) Size: KB |
Jun-03-2024 | 241013498 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-004061 (33 Act) Size: 0 KB |
May-22-2024 | 24973893 |
Recent 20 filings. View all XPENG INC. filings
Thanks I look forward to using the product to improve my skin tone
Huge help thank you for your help .. y'all make it so much easier
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by